Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/48796
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2019-11-20T11:10:49Z | - |
dc.date.available | 2019-11-20T11:10:49Z | - |
dc.date.issued | 2017-09 | - |
dc.identifier.citation | Vella, J., Wirth, F., Serracino-Inglott, A., & Azzopardi, L. M. (2017, September). Serum digoxin concentrations: clinical signals. Poster session presented at the 77th FIP Annual Conference, Seoul, Republic of Korea. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/48796 | - |
dc.description.abstract | A poster presentation regarding serum digoxin concentrations. Introduction: Digoxin, as a treatment option in cardiology, is limited by its narrow therapeutic index. • Current European Society of Cardiology (ESC) guidelines provide a Class 1 Level of Evidence B recommendation for digoxin in atrial fibrillation, and classify it as a treatment of uncertain benefit in heart failure. • Clinical guidelines recommend targeting a serum digoxin concentration (SDC) between 0.5 and 0.9 ng/ml, or <1.0 ng/ml. Aims: • To determine the number of patients on digoxin in Malta • To analyse SDCs recorded at Mater Dei Hospital (MDH) • To determine adherence to the clinically recommended target SDC • To assess queries concerning digoxin processed by the Drug Information Unit (DIU) at MDH | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | University of Malta. Department of Pharmacy | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Digoxin | en_GB |
dc.subject | Drug monitoring -- Research -- Malta | en_GB |
dc.subject | Cardiotonic agents | en_GB |
dc.subject | Heart failure -- Chemotherapy | en_GB |
dc.subject | Atrial fibrillation -- Treatment | en_GB |
dc.title | Serum digoxin concentrations : clinical signals | en_GB |
dc.type | presentation | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | N/A | en_GB |
dc.contributor.creator | Vella, John | - |
dc.contributor.creator | Wirth, Francesca | - |
dc.contributor.creator | Serracino-Inglott, Anthony | - |
dc.contributor.creator | Azzopardi, Lilian M. | - |
Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Serum_digoxin_concentrations_clinical_signals_2017.pdf | 814.01 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.